TABLE 1.
sEVs-ncRNAs | Source | Recipient Cells | Roles/Mechanisms | References |
---|---|---|---|---|
miR-6780b-5p | Ascites | OC cells | Induces epithelial–mesenchymal transition of OC cells | Cai et al. (2021) |
miR-330-3p | Plasma cells | OC cells | Promotes core epithelial-mesenchymal transition programs | Yang et al. (2021b) |
lncRNA SPOCD1-AS | OC cells | Peritoneal mesothelial cells | Remodels mesothelial cells via interacting with G3BP1 | Wang et al. (2021a) |
circWHSC1 | OC cells | Peritoneal mesothelial cells | Sponges miR-145 and miR-1182 to promote proliferation and invasion of OC cells | Zong et al. (2019) |
circPUM1 | OC cells | Peritoneal mesothelial cells | Sponges miR-615-5p and miR-6753-5p to inhibit apoptosis via up-regulating NF-κB and MMP2 | Guan et al. (2019) |
miR-630 | OC cells | Normal fibroblasts | Facilitates CAFs activation | Cui et al. (2021) |
miR-221-3p | M2-phenotype macrophages | OC cells | Promotes proliferation and G1/S transition of OC cells | Li and Tang, (2020) |
miR-21-3p, miR-125b-5p, miR-181d-5p | ||||
miR-940 | Hypoxic OC cells | Macrophages | Induce polarization of M2-phenotype macrophages | (Chen et al., 2017; Chen et al., 2018) |
miR-29a-3p | ||||
miR-21-5p | TAMs | CD4+ T cells | Suppress STAT3 and result in the imbalance of Treg/Th17 cells | Zhou et al. (2018) |
miR-141-3p | OC cells | HUVECs | Promotes endothelial cells migration and angiogenesis | Masoumi-Dehghi et al. (2020) |
miR-205 | OC cells | HUVECs | Increases microvessel density | He et al. (2019) |
OC, ovarian cancer; CAFs, cancer-associated fibroblasts; TAMs, tumor-associated macrophages; HUVECs, human umbilical vein endothelial cells.